Table 4 Prevalence of multidrug resistance among Streptococcus pneumoniae isolates collected during the PROTEKT US study Years 1–4 (2000–2004) according to US region
Proportion of isolates (n [%]) | ||||
|---|---|---|---|---|
Region | Year 1 | Year 2 | Year 3 | Year 4 |
North-central | 727 (34.4) | 651 (29.8) | 730 (30.1) | 599 (30.0) |
Northeast | 1,064 (28.7) | 750 (23.5) | 883 (26.0) | 670 (24.1) |
Northwest | 108 (25.6) | 120 (22.6) | 124 (22.8) | 95 (21.9) |
South-central | 635 (43.6) | 498 (37.4) | 660 (38.2) | 506 (38.0) |
Southeast | 474 (44.6) | 491 (35.3) | 487 (33.9) | 322 (31.4) |
Southwest | 481 (35.7) | 394 (27.9) | 306 (22.4) | 161 (17.4) |
USA total | 3,489 (34.5) | 2,904 (28.9) | 3,190 (29.3) | 2,353 (27.7) |